Jan 12, 2021 / 03:50PM GMT
James Daniel Gordon - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, and good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, at the JPMorgan Healthcare Conference, it's my pleasure to introduce the GSK session with GSK Chief Scientific Officer and President of R&D, Hal Barron.
Today, we'll have a 20-minute presentation from Hal, and then we're going to take 20 minutes of questions. And then, we'll also be joined by other members of GSK executive team, CFO, Iain Mackay; and President of Global Pharmaceuticals, Luke Miels. And you can immediately start registering your questions. The way you do this is with the Q&A function that's associated with this presentation on the conference website. And then I'll be reading out your questions from there.
So with that said, I'd like to welcome Hal to the conference, and Hal, over to you for the presentation.
Hal V. Barron - GlaxoSmithKline plc - Chief Scientific Officer, President of R&D and Director
Good morning. Thank you,
GlaxoSmithKline PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers